The FDA has just approved the world’s first 3D-printed medication, SPRITAM. The seizure drug is meant to be customized for high dosage treatments, and was developed with Aprecia’s ZipDose technology.
SPRITAM’s 3D-printed designed makes it water soluble with a minimal amount of liquid, which absorbs into the blood stream in less than 10 seconds.“By combining 3DP technology with a highly-prescribed epilepsy treatment, SPRITAM is designed to fill a need for patients who struggle with their current medication experience,” Don Wetherhold, Aprecia’s Chief Executive Officer of Aprecia, said in a press release
New York, meet the world’s tech scene
5,000 Tech leaders are coming to NYC this November to learn and do business. This is your chance to join them.
The use of 3D-printing for medical purposes is not new, but this is the first time the FDA has approved a drug designed by 3D-printing.
➤ FDA approves the first 3D printed drug product [Aprecia]